OptionsHouse

Options Trading News

September 27, 2013  Fri 7:26 AM CT

NKE: SEE CHART GET CHAIN FIND STRATEGIES

Lower Costs Boost Margins

Nike earned $0.86 a share in its first quarter, beating the $0.78 average analyst estimate. Revenue of $6.97 billion also exceeded the $6.96 billion consensus number. Management said lower input costs and reduced discounting boosted margins. Orders remain strong as well. NKE rallies 6 percent before the opening bell on my tradeMONSTER platform.

Finish Line Earnings, Sales Beat Consensus

Finish Line reported second-quarter net income of $0.54 on sales of $436 million. Analysts had only expected $0.45 and $426.4 million, respectively. Management also raised its full-year guidance for comparable sales. FINL climbs 9 percent in the premarket.

Nektar Tanks on Drug Trial Disappointment

Nektar Therapeutics announced that its NKTR-181 painkiller failed to meet its primary endpoint in a Phase 2 study. NKTR sinks 22 percent in early trading.

Share this article with your friends


Related Stories

NKE

Investor hopes to run higher with Nike

July 29, 2016

A large trader is extending a bullish position in the athletic-apparel giant, which reported bearish results on June 28 and is down 5 percent in the last three months.

OptionsHouse

Premium Services

Education & Strategy

Dissecting a big institutional trade

This week's column will study a recent call ratio spread. We're not recommending using this strategy because it has potentially huge risk. But we can learn from this different use of options by a large institutional investor.

View more education articles »